157 related articles for article (PubMed ID: 23034483)
41. AAVS1-Targeted Plasmid Integration in AAV Producer Cell Lines.
Luo Y; Frederick A; Martin JM; Scaria A; Cheng SH; Armentano D; Wadsworth SC; Vincent KA
Hum Gene Ther Methods; 2017 Jun; 28(3):124-138. PubMed ID: 28504553
[TBL] [Abstract][Full Text] [Related]
42. Site-specific integration by adeno-associated virus.
Linden RM; Ward P; Giraud C; Winocour E; Berns KI
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11288-94. PubMed ID: 8876128
[TBL] [Abstract][Full Text] [Related]
43. Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome-targeting nonviral particle.
Lamartina S; Roscilli G; Rinaudo D; Delmastro P; Toniatti C
J Virol; 1998 Sep; 72(9):7653-8. PubMed ID: 9696870
[TBL] [Abstract][Full Text] [Related]
44. Selective cleavage of AAVS1 substrates by the adeno-associated virus type 2 rep68 protein is dependent on topological and sequence constraints.
Lamartina S; Ciliberto G; Toniatti C
J Virol; 2000 Oct; 74(19):8831-42. PubMed ID: 10982325
[TBL] [Abstract][Full Text] [Related]
45. Characterization of adeno-associated virus rep protein inhibition of adenovirus E2a gene expression.
Nada S; Trempe JP
Virology; 2002 Feb; 293(2):345-55. PubMed ID: 11886255
[TBL] [Abstract][Full Text] [Related]
46. Binding sites for adeno-associated virus Rep proteins within the human genome.
Wonderling RS; Owens RA
J Virol; 1997 Mar; 71(3):2528-34. PubMed ID: 9032395
[TBL] [Abstract][Full Text] [Related]
47. Gene therapy for hemophilia B with liver-specific element mediated by Rep-RBE site-specific integration system.
Xu Z; Ye J; Zhang A; Xie L; Shen Q; Xue J; Chen J
J Cardiovasc Pharmacol; 2015 Feb; 65(2):153-9. PubMed ID: 25295466
[TBL] [Abstract][Full Text] [Related]
48. Sites of recombinant adeno-associated virus integration.
Rivadeneira ED; Popescu NC; Zimonjic DB; Cheng GS; Nelson PJ; Ross MD; DiPaolo JA; Klotman ME
Int J Oncol; 1998 Apr; 12(4):805-10. PubMed ID: 9499439
[TBL] [Abstract][Full Text] [Related]
49. Packaging of human chromosome 19-specific adeno-associated virus (AAV) integration sites in AAV virions during AAV wild-type and recombinant AAV vector production.
Hüser D; Weger S; Heilbronn R
J Virol; 2003 Apr; 77(8):4881-7. PubMed ID: 12663794
[TBL] [Abstract][Full Text] [Related]
50. Structural Insights into the Assembly of the Adeno-associated Virus Type 2 Rep68 Protein on the Integration Site AAVS1.
Musayev FN; Zarate-Perez F; Bishop C; Burgner JW; Escalante CR
J Biol Chem; 2015 Nov; 290(46):27487-99. PubMed ID: 26370092
[TBL] [Abstract][Full Text] [Related]
51. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome.
Hüser D; Gogol-Döring A; Lutter T; Weger S; Winter K; Hammer EM; Cathomen T; Reinert K; Heilbronn R
PLoS Pathog; 2010 Jul; 6(7):e1000985. PubMed ID: 20628575
[TBL] [Abstract][Full Text] [Related]
52. Adeno-associated virus site-specifically integrates into a muscle-specific DNA region.
Dutheil N; Shi F; Dupressoir T; Linden RM
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4862-6. PubMed ID: 10758163
[TBL] [Abstract][Full Text] [Related]
53. Rep68 protein of adeno-associated virus type 2 interacts with 14-3-3 proteins depending on phosphorylation at serine 535.
Han SI; Kawano MA; Ishizu K; Watanabe H; Hasegawa M; Kanesashi SN; Kim YS; Nakanishi A; Kataoka K; Handa H
Virology; 2004 Mar; 320(1):144-55. PubMed ID: 15003870
[TBL] [Abstract][Full Text] [Related]
54. Development of animal models for adeno-associated virus site-specific integration.
Rizzuto G; Gorgoni B; Cappelletti M; Lazzaro D; Gloaguen I; Poli V; Sgura A; Cimini D; Ciliberto G; Cortese R; Fattori E; La Monica N
J Virol; 1999 Mar; 73(3):2517-26. PubMed ID: 9971837
[TBL] [Abstract][Full Text] [Related]
55. A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay.
Cathomen T; Collete D; Weitzman MD
J Virol; 2000 Mar; 74(5):2372-82. PubMed ID: 10666268
[TBL] [Abstract][Full Text] [Related]
56. Integration of adeno-associated virus (AAV) and recombinant AAV vectors.
McCarty DM; Young SM; Samulski RJ
Annu Rev Genet; 2004; 38():819-45. PubMed ID: 15568995
[TBL] [Abstract][Full Text] [Related]
57. Transgene expression after rep-mediated site-specific integration into chromosome 19.
Philpott NJ; Gomos J; Falck-Pedersen E
Hum Gene Ther; 2004 Jan; 15(1):47-61. PubMed ID: 14965377
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the mouse adeno-associated virus AAVS1 ortholog.
Dutheil N; Yoon-Robarts M; Ward P; Henckaerts E; Skrabanek L; Berns KI; Campagne F; Linden RM
J Virol; 2004 Aug; 78(16):8917-21. PubMed ID: 15280500
[TBL] [Abstract][Full Text] [Related]
59. Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVS1.
Owens RA
Curr Gene Ther; 2002 May; 2(2):145-59. PubMed ID: 12109212
[TBL] [Abstract][Full Text] [Related]
60. Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration.
Smith JR; Maguire S; Davis LA; Alexander M; Yang F; Chandran S; ffrench-Constant C; Pedersen RA
Stem Cells; 2008 Feb; 26(2):496-504. PubMed ID: 18024421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
